NCT Number: NCT04537507
Atrial Fibrillation and Non-obstructive Coronary Lesions
Atrial fibrillation (AF) is the most common cardiac arrhythmia associated with excessive risk of ischemic stroke and heart failure as well as reduced life expectancy. On the other hand, chronic coronary syndromes (CCS) remains the main cause of morbidity and mortality in an aging population. Both disease entities share common risk factors such as hypertension, diabetes and obesity The purpose of the study is to investigate the hypothesis indicating lack of significant coronary lesions in AF vs. sinus rhythm (SR) patients.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Observational
Primary location
Department of Cardiology, Medical University of Bialystok, Bialystok, Poland, Bialystok, Poland
About this study
Atrial fibrillation (AF) and chronic coronary syndromes (CCS) share common risk factors and both disease entities frequently co-exist. Additionally, AF symptoms may mimic CCS. Objectives: To investigate the hypothesis indicating lack of significant coronary lesions in AF vs. sinus rhythm (SR) patients.
The prevalence of CCS in patients with AF varies from 17% to 47% whereas AF in patients with CCS is much less common, ranging from 0.2% to 5.Patients with AF more often have concomitant CCS as compared with sinus rhythm controls. Additionally, AF is more frequently present in patients with either peripheral- or cerebrovascular artery disease than in non-atherosclerotic individuals We conducted a multi-center retrospective study including consecutive patients referred for elective coronary angiography.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Coronary angiography
Exclusion criteria
- We excluded patients with acute coronary syndromes (ACS), Tako-tsubo cardiomiopathy and history of ischemic heart disease, as well as those referred for coronary angiography before heart valve surgery. Prior cardiosurgical valve replacement was also the exclusion criterion.
Treatment and study plan
Primary outcomes
-
Coronary artery disease
Time frame: Through study completion, an average of 8 years
Number of Participants with significant findings on coronary angiography
Sponsors and collaborators
Lead sponsor
Medical University of Bialystok
Other
Collaborators
- I.M. Sechenov First Moscow State Medical University
- Liverpool Heart and Chest Hospital NHS Foundation Trust
- Medical University of Gdansk
Registry information
Official study title
Is Atrial Fibrillation is Associated With Non-significant Coronary Angiography Findings?
Acronym: AF-CAD
Important dates
- Study start
- 2010
- Primary completion
- 2021
- Study completion
- 2022
- First posted
- Sep 3, 2020
- Registry last updated
- Jan 10, 2022
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Medical and Sociological Characterization of the Population of Patients Admitted for a First Ablation of Atrial Fibrillation in the Occitanie Ouest Region
NCT06618833
Arrhythmias, Cardiac, Atrial Fibrillation
Toulouse, France
View Trial DetailsDetecting Atrial Fibrillation in Patients With an Embolic Stroke of Undetermined Source (From the DAF-ESUS Registry)
NCT04761315
Arrhythmias, Cardiac, Atrial Fibrillation
View Trial DetailsOdiparcil For The Prevention Of Venous Thromboembolism
NCT00244725
Arrhythmias, Cardiac, Atrial Fibrillation
Birmingham, Alabama, United States
View Trial DetailsEvaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation
NCT00402363
Arrhythmias, Cardiac, Atrial Fibrillation
Birmingham, Alabama, United States
View Trial Details